Patent · US Active

Quantitative HIV phenotype or tropism assay

US8790870B2 · kind B2 · utility

0Cited by

4References

11Claims

0Family size

Assignee

Virco BVBA · BE

Inventors

Lieven Stuyver · Borsbeke, BE
Kurt Van Baelen · Westerlo, BE
Ina Isabel Vandenbroucke · Verrebroek, BE

Key dates

Filing date	Feb 2, 2007
Grant date	Jul 29, 2014
Priority date	—
Expiry date	Nov 24, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q1/703
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention concerns a method for predicting quantitative phenotype, e.g. gag-phenotype, integrase phenotype or tropism in a patient infected by Human Immunodeficiency Virus (HIV).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.